BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Products » Cell Therapy Manufacturing Survey – Selection Criteria for Choosing a CMO Partner
Sale!

Cell Therapy Manufacturing Survey – Selection Criteria for Choosing a CMO Partner

Category: Stem Cells Tag: survey
  • Description

Description

In this 21-page, 50+ respondent survey, cell therapy manufacturing executives reveal when and why they choose to partner with a cell therapy contact manufacturing organization (CMO).

Discover class-defining bioproduction tools.

Importantly, it reveals the selection criteria that cell therapy executives use to select a CMO partner, as well as their perspectives on manufacturing capacity, geography, pure-play versus hybrid CMOs, and much more.

A contract manufacturing organization (CMO) is a company that serves cell therapy companies on a contract basis. Common cell therapy CMO services include cell therapy product development, manufacturing, clinical trial support, and commercial supply.

Questions asked in this survey include:

  1. Which organization do you represent?
  2. Which position do you hold within your company?
  3. What is your job function?
  4. Where is your company headquartered?
  5. At what stage is your most advanced cell therapy product?
  6. Thinking about your most advanced therapy, is it autologous or allogeneic?
  7. At what stage of development would you expect to engage a CMO partner?
  8. For how long do you expect to engage the services of a CMO?
  9. What key things are critical for a CMO to offer in order to have a long-term partnership with a company like yours?
  10. How important is having capacity in multiple regions or having multiple locations in a region for close proximity to the customer?
  11. In your experience, who has the biggest influence on the choice of raw material specification? (eg. Cell media, single use disposables, etc.)
  12. At what stage in developing a cell therapy is this decision made?
  13. How do you view CMOs that are or may work extensively with other cell therapy companies? Do you view them more favorably (e.g. because of expertise or scale) or less favorably (e.g. due to competition)?
  14. Hybrid CMOs develop cell therapy products and provide CMO services. Pure play CMOs function exclusively as a CMO service provider. Which CMO type do you prefer?
  15. What is your selection criteria when choosing a CMO partner?

For a geographic breakdown of the respondents, 40% were from the USA, 20% were from Europe, 16% were from Asia, 5% were from South America, and 19% were rest-of-world (ROW).

Completed August 2017, this cell therapy manufacturing survey of 50+ respondents is an indispensable resource for CMO and CDMOs specializing in the rapidly evolving cell and gene therapy industry.

For a limited-time, you can claim this 21-page survey for only $97 and have access to it for life.

To prevent this data from getting shared, we are releasing a limited quantity and then we will pull it from the site. Your product will be delivered instantly as a PDF download.

Of course, your investment is also backed by a full 60-Day Money Back Guarantee.

5 / 5 ( 49 votes )

$197 $97

Related products

  • Sale! Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends

    [SALE] Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends – 2021

    $3,197 – $3,997
    Select options
  • Sale! BioInformant Audience

    Reach BioInformant’s Audience with Your Press Announcement

    $397 $297
    Add to cart
  • COVID-19 Coronavirus Market Report

    COVID-19 Global Market: Cell Therapies, Diagnostics, Treatments, Vaccines

    $3,495 – $4,497
    Select options
  • U.S. Cord Blood Banking Survey

    Cord Blood Banking Survey of U.S. Parents [2017]

    $197
    Add to cart

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Cell Therapy Manufacturing Survey - Selection Criteria for Choosing a CMO Partner
    Rated 0 out of 5
    $197 $97
  • Stem Cell Fact Sheet - Types of Stem Cells and their Use in Medicine
    Rated 0 out of 5
    $10
  • Global Database of Research Supply Companies Global Database of Research Supply Companies 2021
    Rated 0 out of 5
    $39
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.